XYL · NYQ · Industrials
Xylem Inc.
Also onShortfallConsensus DriftCrosscheck
Implied value per share
USD 92.16
Market price
USD 107.56
Implied upside
-14.3%
5-year forecast · Perpetuity growth terminal value · Mid-year discounting · Base case
Value Per Share
Same forecast, different terminal treatment. Percentages vs price.
Forecast Cashflows
Reporting currency (USD). Outflows negative.
| Line | FY26 | FY27 | FY28 | FY29 | FY30 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | USD 10.6bn | USD 12.5bn | USD 14.8bn | USD 17.4bn | USD 20.5bn | +17.8% |
| EBIT | USD 1.3bn | USD 1.5bn | USD 1.8bn | USD 2.1bn | USD 2.5bn | +17.8% |
| NOPAT | USD 1.1bn | USD 1.2bn | USD 1.5bn | USD 1.7bn | USD 2.0bn | +17.8% |
| Add depreciation & amortisation | USD 615.4m | USD 725.2m | USD 854.5m | USD 1.0bn | USD 1.2bn | +17.8% |
| Less capital expenditure | USD -395.5m | USD -466.0m | USD -549.2m | USD -647.1m | USD -762.5m | +17.8% |
| Less increase in working capital | USD -184.6m | USD -217.5m | USD -256.3m | USD -302.0m | USD -355.9m | +17.8% |
| Free cashflow to firm | USD 1.1bn | USD 1.3bn | USD 1.5bn | USD 1.8bn | USD 2.1bn | +17.8% |
| Discount factor | 0.9534 | 0.8667 | 0.7878 | 0.7161 | 0.6510 | - |
| Present value | USD 1.0bn | USD 1.1bn | USD 1.2bn | USD 1.3bn | USD 1.4bn | +7.1% |
| Present Value Of The Forecast | USD 6.0bn | |||||
Discount Rate
Source shown per component. All overridable above.
| Risk-free rate | 5.00% | US 10-year Treasury (^TNX) |
| Equity risk premium | 5.50% | Market assumption |
| Beta | 1.000 | Reported 1.000, pulled toward 1.0 (Blume) |
| Cost of equity | 10.50% | Risk-free + beta x equity risk premium |
| Cost of debt | 5.00% | Floored at the risk-free rate (implied cost of debt was lower) |
| Market capitalisation | USD 25.1bn | 92.4% of capital |
| Total debt | USD 2.1bn | 7.6% of capital, book value as a proxy |
| Tax rate | 18.7% | Effective, capped at statutory |
| WACC | 10.01% | E/V x Re + D/V x Rd x (1 - t) |
Terminal Value
Perpetuity growth is intrinsic. The exit multiple defaults to the company's current EV/EBITDA, so it answers a different question - what the shares are worth if today's rating holds and EBITDA grows as forecast.
Perpetuity growth at 2.50%
74% of EV
- Forecast FCFF, final year
- USD 2.1bn
- Capex at depreciation, working capital in reinvestment
- USD 2.6bn
- Less reinvestment at g/ROIC (25.0% of NOPAT)
- USD -639.5m
- Capitalised
- USD 1.9bn
- ROIC (WACC floor)
- 10.0%
- Terminal value, undiscounted
- USD 26.2bn
- Terminal value, discounted
- USD 17.1bn
- Enterprise value
- USD 23.1bn
- Less net debt
- USD 584.0m
- Equity value
- USD 22.5bn
Exit at 13.5x EBITDA
84% of EV
- Terminal value, undiscounted
- USD 49.9bn
- Terminal value, discounted
- USD 32.5bn
- Enterprise value
- USD 38.5bn
- Less net debt
- USD 584.0m
- Equity value
- USD 37.9bn
Spread between methods: 51%.
Sensitivity
Value per share (USD) by discount rate and long-run growth.
| Long-run growth | |||||
|---|---|---|---|---|---|
| Discount rate | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
| 8.01% | 117.45 | 117.91 | 118.37 | 118.84 | 119.30 |
| 9.01% | 102.99 | 103.39 | 103.78 | 104.18 | 104.57 |
| 10.01% | 91.47 | 91.81 | 92.16 | 92.50 | 92.84 |
| 11.01% | 82.09 | 82.39 | 82.69 | 82.98 | 83.28 |
| 12.01% | 74.31 | 74.57 | 74.83 | 75.10 | 75.36 |
Outlined: this model. Green text: above today's price of 107.56. Shading: distance from this model's own value.
Priced In
What each input would have to be to justify the current price, one at a time.
| Input | Model | Implied | Gap |
|---|---|---|---|
| Revenue growth, every year | 17.8% | 22.0% | +4.2pp |
| EBIT margin | 12.2% | 14.6% | +2.4pp |
| Discount rate | 10.0% | 8.7% | -1.3pp |
Live formulas, not pasted numbers - edit a driver and the workbook reprices.
Yahoo Finance and RBA data. General information, not advice. Methodology.